Term ends Dec 12, 2026 · High confidence
20-year base term ends Jun 24, 2028
Held by Tersera Therapeutics, LLC
Filed Jun 24, 2008 as application 12/144,953 · Granted Jan 10, 2012
Base term plus 68 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2008
2028
Clock starts
Jun 24, 2008
Jun 24, 2008
Term ends
Dec 12, 2026
Dec 12, 2026
Granted
Jan 10, 2012
Jan 10, 2012
base term
after the term ends
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
68
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,553,840, US 7,709,493, US 7,723,345.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
This patent's term runs 68 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 24, 2008, when this application, 12/144,953, was filed | Jun 24, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +68 days, USPTO patent term adjustment record | Aug 31, 2028 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,553,840, US 7,709,493, US 7,723,345) | capped to Dec 12, 2026 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 12, 2026 | High confidence |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 12, 2008 Reel 21372, frame 624 | Brown, Philip Manton; Liu, Qingyun | Lexicon Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Mar 17, 2022 Reel 59432, frame 709 | Lexicon Pharmaceuticals, Inc. | Oxford Finance LLC, as Collateral Agent | Security Interest |
| Apr 4, 2023 Reel 63215, frame 724 | Tersera Therapeutics LLC | Antares Capital LP, as Agent | Security Interest |
| Apr 5, 2023 Reel 63227, frame 852 | Tersera Therapeutics LLC | Newstone Capital Partners, LLC | Security Interest |
| Aug 9, 2023 Reel 64538, frame 33 | Lexicon Pharmaceuticals, Inc. | Tersera Therapeutics, LLC | Assignment of Assignor's Interest |
| Jan 7, 2025 Reel 69835, frame 704 | Newstone Capital Partners, LLC | Tersera Therapeutics LLC | Release of Intellectual Property Security Agreement Recorded at R/F 63227/0852 |
| May 5, 2026 reel/frame not recorded | Oxford Finance LLC | Lexicon Pharmaceuticals, Inc. | Release of Security Interest |
| May 5, 2026 reel/frame not recorded | Oxford Finance LLC | Lexicon Pharmaceuticals | Release of Security Interest |
| May 5, 2026 Reel 75545, frame 601 | Oxford Finance LLC | Lexicon Pharmaceuticals, Inc.; Lexicon Pharmaceuticals | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Dec 2026
Term ends Dec 12, 2026. No further fees fall due before then
Note
The 68 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 7,553,840, US 7,709,493, US 7,723,345.
Citations
7
later US patents cite this one
That is below the median of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.